AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22633044 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stenting (CAS)
Number of subjects: 55
Study 22633044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral protection device (CPD) used in treatment
Number of subjects: 55
Study 22633044 — intervention group
Group type: EXPERIMENTAL
Intervention: Open- and closed-cell stents
Number of subjects: 55
Study 20932523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 20
Study 20932523 — intervention group
Group type: COMPARATOR
Intervention: Proximal Femoral Nail (PFN)
Number of subjects: 20
Study 20932523 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DHS and PFN
Number of subjects: 20
Study 19335077 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic piezoelectric devices
Number of subjects: 11
Study 19335077 — intervention group
Group type: COMPARATOR
Intervention: Curets (Control)
Number of subjects: 11
Study 16430773 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized BMD feedback with low BMD
Number of subjects: 470
Study 16430773 — intervention group
Group type: COMPARATOR
Intervention: Osteoporosis information leaflet
Number of subjects: 470
Study 16430773 — intervention group
Group type: COMPARATOR
Intervention: Osteoporosis self-management course
Number of subjects: 470
Study 16430773 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting calcium supplements
Number of subjects: 470
Study 16430773 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent self-reported change in physical activity levels
Number of subjects: 470
Study 15574614 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visits
Number of subjects: 743
Study 15574614 — intervention group
Group type: COMPARATOR
Intervention: Comparison services
Number of subjects: 743
Study 11018197 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug treatment
Number of subjects: 264
Study 8774298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 88
Study 8774298 — intervention group
Group type: COMPARATOR
Intervention: Pericervical insemination
Number of subjects: 88
Study 1466432 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl/propofol anaesthesia (propofol infusion 6 mg.kg‐1.h‐1, reduced after 10 min)
Number of subjects: 20
Study 1466432 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl/enflurane anaesthesia (enflurane 0.8% inspired concentration, reduced to 0.6%)
Number of subjects: 20
Study 6230648 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin (2 g dose administered intravenously 1 hour before surgery)
Number of subjects: 100
Study 6230648 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mezlocillin)
Number of subjects: 100
Study 30693399 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implant placement + deproteinized bovine bone derived with collagen
Number of subjects: 22
Study 30693399 — intervention group
Group type: COMPARATOR
Intervention: Immediate implant placement without biomaterial
Number of subjects: 22
Study 28375891 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge plate osteosynthesis
Number of subjects: 110
Study 28375891 — intervention group
Group type: COMPARATOR
Intervention: Functional brace
Number of subjects: 110
Study 26500463 — intervention group
Group type: EXPERIMENTAL
Intervention: Zeolite supplementation (1.85 g per day for 12 weeks)
Number of subjects: 52
Study 26500463 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 52
Study 23917308 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise program (12 weeks, based on location of bone lesions)
Number of subjects: 20
Study 23917308 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study 21552183 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 μg mpHBV
Number of subjects: 1718
Study 21552183 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg mpHBV
Number of subjects: 1718
Study 21552183 — intervention group
Group type: COMPARATOR
Intervention: Recombivax‐HB (5 μg)
Number of subjects: 1718
Study 21552183 — intervention group
Group type: COMPARATOR
Intervention: Engerix‐B (10 μg)
Number of subjects: 1718
Study 19843809 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg oral ondansetron the evening before surgery plus IV 8 mg ondansetron 15 min before subarachnoid anesthesia
Number of subjects: 50
Study 19843809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17185094 — intervention group
Group type: COMPARATOR
Intervention: Standard video colonoscope (Method A)
Number of subjects: 6
Study 17185094 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscope with retrograde-viewing auxiliary device (Method B)
Number of subjects: 6
Study 15465140 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D conformal radiotherapy (66 Gy)
Number of subjects: 266
Study 15465140 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (66 Gy)
Number of subjects: 266
Study 11906340 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic quilt use
Number of subjects: 758
Study 11906340 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing synthetic upper bedding use
Number of subjects: 758
Study 10088569 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH, 0.2 mg/kg per day intramuscularly (n = 10)
Number of subjects: 20
Study 10088569 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 20
Study 7502702 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1 g of calcium)
Number of subjects: 15
Study 7502702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1953991 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.75 g/kg body weight in 500 ml carbon dioxide‐free mineral water)
Number of subjects: 12
Study 1953991 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (1,000 mg powdered, average 13.1 mg/kg body weight)
Number of subjects: 12
Study 1953991 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and acetylsalicylic acid combination
Number of subjects: 12
Study 7008940 — intervention group
Group type: EXPERIMENTAL
Intervention: Rociverine
Number of subjects: 300
Study 7008940 — intervention group
Group type: EXPERIMENTAL
Intervention: Butylscopolamine bromide
Number of subjects: 300
Study 7008940 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 300
Study 6091382 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexon (absorbable polyglycolic acid)
Number of subjects: 520
Study 6091382 — intervention group
Group type: COMPARATOR
Intervention: Mersilene
Number of subjects: 520
Study 28831814 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting group programme
Number of subjects: 545
Study 26827999 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 99
Study 26827999 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomilla recutita
Number of subjects: 99
Study 26827999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 24755382 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiron (sirolimus-eluting stent with abluminal biodegradable polymer)
Number of subjects: 58
Study 24755382 — intervention group
Group type: COMPARATOR
Intervention: Cronus (stent without polymer coating or drug elution)
Number of subjects: 58
Study 24755382 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiron
Number of subjects: 58
Study 24755382 — intervention group
Group type: COMPARATOR
Intervention: Cronus
Number of subjects: 58
Study 24755382 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 22762317 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (≥800 IU daily)
Number of subjects: 31022
Study 22762317 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D supplementation (unspecified dosage)
Number of subjects: 31022
Study 20531072 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaptive film (Steri Strip S; 3 M company)
Number of subjects: 25
Study 20531072 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular Monocryl sutures (3-0)
Number of subjects: 25
Study 20531072 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaptive film
Number of subjects: 25
Study 20531072 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular Monocryl sutures
Number of subjects: 25
Study 20531072 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaptive film and Subcuticular Monocryl sutures
Number of subjects: 25
Study 18784223 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (40 mg/kg) at baseline
Number of subjects: 378
Study 18784223 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 378
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (50 microg perivaginally)
Number of subjects: 65
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone gel (0.5 mg intracervically)
Number of subjects: 65
Study 15916656 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN) (0.5 mg perivaginally)
Number of subjects: 65
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (50 microg perivaginally) in severely unfavorable cervix (Bishop score ≤3)
Number of subjects: 65
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone gel (0.5 mg intracervically) in severely unfavorable cervix (Bishop score ≤3)
Number of subjects: 65
Study 15916656 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN) (0.5 mg perivaginally) in severely unfavorable cervix (Bishop score ≤3)
Number of subjects: 65
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 65
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 65
Study 15916656 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone
Number of subjects: 65
Study 15916656 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 65
Study 12643609 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg at night
Number of subjects: 60
Study 12643609 — intervention group
Group type: COMPARATOR
Intervention: pantoprazole 40 mg in the morning
Number of subjects: 60
Study 15613189 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend headache in patients with migraine without aura
Number of subjects: 240
Study 15613189 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend headache in patients with episodic tension-type headache
Number of subjects: 240
Study 15613189 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical features of weekend headache
Number of subjects: 240
Study 15613189 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggering factors for weekend headache
Number of subjects: 240
Study 8701408 — intervention group
Group type: EXPERIMENTAL
Intervention: APC resistance test using Coatest APC Resistance
Number of subjects: 393
Study 8701408 — intervention group
Group type: EXPERIMENTAL
Intervention: APC resistance test
Number of subjects: 393
Study 2066747 — intervention group
Group type: EXPERIMENTAL
Intervention: Funded communities (intervention group)
Number of subjects: 11
Study 2066747 — intervention group
Group type: COMPARATOR
Intervention: Unfunded comparison groups (control group)
Number of subjects: 11
Study 6405584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (15 mg)
Number of subjects: 80
Study 6405584 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 80
Study 31142336 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day training in trauma inquiry ('Learning How to Ask') plus a refresher session 3 months later
Number of subjects: 148
Study 31142336 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 148
Study 28440669 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic 4D CTA in the shuttle mode (Group A)
Number of subjects: 54
Study 28440669 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash 4D CTA in the high-pitch mode (Group B)
Number of subjects: 54
Study 28440669 — intervention group
Group type: COMPARATOR
Intervention: Standard triphasic acquisition protocol (Group C)
Number of subjects: 54
Study 26863054 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectralis optical coherence tomography (OCT)
Number of subjects: 133
Study 24495287 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal autopsy (VA) system as part of the Indian Million Death Study (MDS)
Number of subjects: 0
Study 24495287 — intervention group
Group type: EXPERIMENTAL
Intervention: MDS cause-specific mortality fractions (CSMFs)
Number of subjects: 0
Study 24495287 — intervention group
Group type: EXPERIMENTAL
Intervention: MDS COD classification system
Number of subjects: 0
Study 24495287 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial physician agreement on COD
Number of subjects: 0
Study 24495287 — intervention group
Group type: COMPARATOR
Intervention: Reliance on urban or hospital data
Number of subjects: 0
Study 22113218 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (40 mg triamcinolone acetonide)
Number of subjects: 45
Study 20511270 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist
Number of subjects: 46
Study 20511270 — intervention group
Group type: COMPARATOR
Intervention: No Checklist
Number of subjects: 46
Study 20511270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 46
Study 17625461 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 12
Study 15708886 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine 150 mg twice daily
Number of subjects: 16
Study 15708886 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 12468950 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg o.d.), levofloxacin (500 mg o.d.), amoxycillin (1 g b.d.) for 7 days
Number of subjects: 160
Study 12468950 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg o.d.), levofloxacin (500 mg o.d.) for 5 days
Number of subjects: 160
Study 12468950 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg o.d.), levofloxacin (500 mg o.d.) for 7 days
Number of subjects: 160
Study 12468950 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg o.d.), levofloxacin (500 mg o.d.) for 10 days
Number of subjects: 160
Study 9844762 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CSA) at a dosage of 3 mg/kg/day
Number of subjects: 103
Study 9844762 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) at a dosage of 0.15 mg/kg/week
Number of subjects: 103
Study 8029807 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day aspirin for seven days
Number of subjects: 13
Study 8029807 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/day aspirin for seven days
Number of subjects: 13
Study 8029807 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/day aspirin for seven days
Number of subjects: 13
Study 8029807 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg aspirin/day for one week
Number of subjects: 13
Study 8029807 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 or 1200 mg aspirin (single dose)
Number of subjects: 13
Study 2925974 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (AIDS risk education, cognitive‐behavioral self‐management training, sexual assertion training, development of steady and self‐affirming social supports)
Number of subjects: 104
Study 2925974 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 104
Study 1079063 — intervention group
Group type: EXPERIMENTAL
Intervention: 51 percent fresh blood (Group 1)
Number of subjects: 50
Study 1079063 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 percent fresh blood (Group 2)
Number of subjects: 50
Study 1079063 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 percent component therapy (Group 3)
Number of subjects: 50
Study 1079063 — intervention group
Group type: COMPARATOR
Intervention: Component therapy
Number of subjects: 50
Study 31298266 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 3598
Study 31298266 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 3598
Study 30715501 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent light regime (FLASH20: 20 min/h + 40 min constant light)
Number of subjects: 270
Study 30715501 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent light regime (FLASH40: 40 min/h + 20 min constant light)
Number of subjects: 270
Study 30715501 — intervention group
Group type: COMPARATOR
Intervention: Control group (continuous light for 16 h/day)
Number of subjects: 270
Study 28706169 — intervention group
Group type: EXPERIMENTAL
Intervention: Movie-based nursing intervention program (60-minute sessions, once per week for 10 weeks)
Number of subjects: 60
Study 26468956 — intervention group
Group type: EXPERIMENTAL
Intervention: High current CD4+ T cell count (>660 cells/mm3)
Number of subjects: 133
Study 26468956 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-per-day dosing regimen
Number of subjects: 133
Study 26468956 — intervention group
Group type: EXPERIMENTAL
Intervention: High CD4+ T cell counts
Number of subjects: 133
Study 26468956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low or intermediate CD4+ T cell counts
Number of subjects: 133
Study 26468956 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of effects of adherence on virological suppression between patients with high vs. low or intermediate CD4+ T cell counts
Number of subjects: 133
Study 24494283 — intervention group
Group type: COMPARATOR
Intervention: Needle retention for 20 min
Number of subjects: 80
Study 24494283 — intervention group
Group type: COMPARATOR
Intervention: Needle retention for 30 min
Number of subjects: 80
Study 24494283 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle retention for 45 min
Number of subjects: 80
Study 24494283 — intervention group
Group type: COMPARATOR
Intervention: Needle retention for 60 min
Number of subjects: 80
Study 21207256 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV detection using immunohistochemical analysis and PCR
Number of subjects: 142
Study 21207256 — intervention group
Group type: COMPARATOR
Intervention: Control group (42 control biopsies)
Number of subjects: 142
Study 19719543 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 306
Study 17906165 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 0
Study 17906165 — intervention group
Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 0
Study 15041595 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg preoperatively
Number of subjects: 60
Study 15041595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11338068 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiophilus (Lactobacillus rhamnosus)
Number of subjects: 206
Study 11338068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 9429011 — intervention group
Group type: EXPERIMENTAL
Intervention: Running Intensive Tennis Training (RIT)
Number of subjects: 54
Study 9429011 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 8490250 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Proximal Vagotomy (SPV)
Number of subjects: 38
Study 8490250 — intervention group
Group type: COMPARATOR
Intervention: Selective Vagotomy with Pyloroplasty (SV + PP)
Number of subjects: 38
Study 8490250 — intervention group
Group type: COMPARATOR
Intervention: Selective Proximal Vagotomy with Pyloroplasty (SPV + PP)
Number of subjects: 38
Study 8490250 — intervention group
Group type: COMPARATOR
Intervention: Unoperated controls
Number of subjects: 38
Study 3010707 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril monotherapy
Number of subjects: 27
Study 3010707 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril and hydrochlorothiazide combination therapy
Number of subjects: 27
Study 30036748 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin-ideal images
Number of subjects: 220
Study 30036748 — intervention group
Group type: COMPARATOR
Intervention: Average images
Number of subjects: 220
Study 30036748 — intervention group
Group type: EXPERIMENTAL
Intervention: High number of likes
Number of subjects: 220
Study 30036748 — intervention group
Group type: EXPERIMENTAL
Intervention: Low number of likes
Number of subjects: 220
Study 27060939 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 25
Study 27060939 — intervention group
Group type: COMPARATOR
Intervention: Memory enhancement training (MET)
Number of subjects: 25
Study 23539433 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-intervention group (grades 1-6)
Number of subjects: 608
Study 23539433 — intervention group
Group type: EXPERIMENTAL
Intervention: Late intervention group (grades 5-6)
Number of subjects: 608
Study 23539433 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 608
Study 22912445 — intervention group
Group type: COMPARATOR
Intervention: 1 × 10(7) cfu C. butyricum/kg of diet (CB2)
Number of subjects: 450
Study 22912445 — intervention group
Group type: COMPARATOR
Intervention: 3 × 10(7) cfu C. butyricum/kg of diet (CB3)
Number of subjects: 450
Study 22912445 — intervention group
Group type: COMPARATOR
Intervention: 10 mg of colistine sulfate/kg of diet (antibiotic)
Number of subjects: 450
Study 22912445 — intervention group
Group type: EXPERIMENTAL
Intervention: C. butyricum
Number of subjects: 450
Study 18963044 — intervention group
Group type: EXPERIMENTAL
Intervention: ACET (Air Conduction Estimated from Tympanometry) formula based on tympanogram categories B, C2, C1, and A.
Number of subjects: 3085
Study 18963044 — intervention group
Group type: EXPERIMENTAL
Intervention: B tympanogram in one ear
Number of subjects: 3085
Study 17324008 — intervention group
Group type: EXPERIMENTAL
Intervention: ISA 247 (0.2 mg/kg bid)
Number of subjects: 193
Study 17324008 — intervention group
Group type: EXPERIMENTAL
Intervention: ISA 247 (0.3 mg/kg bid)
Number of subjects: 193
Study 17324008 — intervention group
Group type: EXPERIMENTAL
Intervention: ISA 247 (0.4 mg/kg bid)
Number of subjects: 193
Study 17324008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193